Package 55910-957-60

{"route": ["ORAL"], "spl_id": "b1a961d6-357a-415e-94f2-a063b3021943", "openfda": {"nui": ["N0000175706", "M0014836"], "upc": ["0012345678905"], "unii": ["6M3C89ZY6R"], "rxcui": ["359818"], "spl_set_id": ["83b053f6-304b-4f9c-8a6d-6649998708b2"], "pharm_class_cs": ["Nicotine [CS]"], "pharm_class_epc": ["Cholinergic Nicotinic Agonist [EPC]"], "manufacturer_name": ["Dolgencorp, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CONTAINER in 1 CARTON (55910-957-60)  / 20 LOZENGE in 1 CONTAINER", "package_ndc": "55910-957-60", "marketing_start_date": "20130808"}], "brand_name": "Rexall Nicotine", "product_id": "55910-957_b1a961d6-357a-415e-94f2-a063b3021943", "dosage_form": "LOZENGE", "pharm_class": ["Cholinergic Nicotinic Agonist [EPC]", "Nicotine [CS]"], "product_ndc": "55910-957", "generic_name": "Nicotine Polacrilex", "labeler_name": "Dolgencorp, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Rexall Nicotine", "active_ingredients": [{"name": "NICOTINE", "strength": "4 mg/1"}], "application_number": "ANDA203690", "marketing_category": "ANDA", "marketing_start_date": "20130808", "listing_expiration_date": "20261231"}